MedPath

A trial to evaluate the efficacy and safety of high temperature processed green tea extract on improvement of memory functio

Not Applicable
Conditions
Not Applicable
Registration Number
KCT0003661
Lead Sponsor
Ewha Womans University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Those who are between the ages of 40 and 65 at the time of screening
- Those who complain subjective memory impairment (who answer yes at least 1 question at Subjective Memory Complaints Questionnaire[SMCQ], or score 2 at Global Deterioration Scale[GDS], and score 26 or more at Mini-Mental State Examination in the Korean version of the CERAD assessment packet[MMSE-KC])

Exclusion Criteria

- Diagnosed with any axis 1 psychiatric disorders (depressive disorder, bipolar disorder, generalized anxiety disorder, substance-related disorder) evaluated with a structured instrument
- Diagnosed with any major medical or neurological disorders assessed during medical history taking, physical examination or experimental tests
- Neuropsychological tests indicate a suspected diagnosis of dementia
- A history of traumatic brain injury with loss of consciousness or convulsion
- Had taken psychotropic drugs within the past 1 month before screening
- Had taken a dietary supplement for improving memory and cognitive skills within the past 1 month before screening
- Had taken a dietary supplement made of green tea extract within the past 1 month before screening, or had consumed more than 4 cups of green tea a day
- Had experienced allergic reaction with ingredient including green tea
- Planning for pregnancy during the period of study participation, currently pregnant or breastfeeding
- Participated in another clinical trial within the past 1 months before screening
- Any contraindications to MRI (i.e., claustrophobia, metallic foreign devices in the body)

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change of attention, memory, executive functions and etc. at 12 weeks assessed by the neuropsychological test battery;Change of cognitive function and memory assessed by the Subjective Memory Complaints Questionnaire (SMCQ)
Secondary Outcome Measures
NameTimeMethod
Change of brain structure, function, and metabolism at 12 weeks assessed by computational analysis of magnetic resonance imaging data
© Copyright 2025. All Rights Reserved by MedPath